Better Therapeutics, Inc. (BTTX) Tops Q1 EPS by 13c

Better Therapeutics, Inc. (NASDAQ: BTTX) reported Q1 EPS of ($0.37), $0.13 better than the analyst estimate of ($0.50). Revenue for the quarter came in at $0 versus the consensus estimate of $0 .

For earnings history and earnings-related data on Better Therapeutics, Inc. (BTTX) click here.

You May Also Be Interested In

• BofA sees Micron EPS topping $230 by FY30, calls peak fears overblown
• INVO Fertility (IVF) Tops Q2 EPS by 105c
• The LGL Group (LGL) Misses Q2 EPS by 8c